Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team
Third party research

Nolato: CMD recap: back to earnings growth focus - ABG

Nolato

This is a third party research report and does not necessarily reflect our views or values

Download report (PDF)
>12% EBITA margin target looks doable...
...more uncertainty on the 8% org. growth target, in our view
Back to earnings growth focus after a couple years of putting out fires


>12% EBITA margin target looks doable...

On its Capital Markets Day today, Nolato gave more colour on the new financial targets presented this morning (see our comment here). The EBITA margin target of >12% implies ~2pp expansion from the '24 base of 9.9%, with roughly equal margin expansion in each segment according to the company. In Medical, the main levers for increasing profitability are gradual improvements in cost optimisation and pricing, particularly in the underperforming North American business. In Engineered, margin expansion will be driven by improving utilisation, not least in the facility in China where VHP production has been phased out, and a positive mix effect as the high-margin Materials sub-segment grows it share of sales. In our view, the margin target looks doable, but the effects above will take some time to fully play out.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.